DAMAE Medical Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 23

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5.82M

  • Investors
  • 14

DAMAE Medical General Information

Description

Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's technology, OCTAV is based on its proprietary technology that enables cellular-resolution imaging of the skin similar to histology, without the need for tissue excision and processing, enabling immediate and non-invasive diagnosis of skin cancers and helping dermatologists to have a deep look at the skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 14 rue Sthrau
  • 75013 Paris
  • France
+33 01 00 00 00 00

DAMAE Medical Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DAMAE Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 03-Feb-2022 $5.82M 00.000 000.00 Completed Generating Revenue
9. Secondary Transaction - Private 10-Sep-2020 00.000 Completed Generating Revenue
8. Grant 01-Sep-2019 00.000 00.000 Completed Generating Revenue
7. Seed Round 19-Apr-2017 00.000 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 13-Oct-2015 00000 Completed Startup
5. Grant 05-Jul-2015 000.00 00000 Completed Startup
4. Accelerator/Incubator 05-Jun-2015 00000 Completed Startup
3. Accelerator/Incubator 24-Mar-2015 00000 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. Seed Round 01-Jul-2014 Completed Startup
To view DAMAE Medical’s complete valuation and funding history, request access »

DAMAE Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
P Shares 100,000 $0.113144 $22.63 $22.63 1x $22.63 22.25%
To view DAMAE Medical’s complete cap table history, request access »

DAMAE Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's technology, OC
Diagnostic Equipment
Paris, France
23 As of 2022
00.000
00.00 0000-00-00
00000000000 00.000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000000000 000000000
Maidstone, United Kingdom
000.00
0.000 0000-00-00
0000000000 0 000.00

000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
0000000000 000000000
Stockholm, Sweden
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DAMAE Medical Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VivoSight Venture Capital-Backed Maidstone, United Kingdom 000.00 0000000000 0 000.00
0000000 Formerly PE-Backed Stockholm, Sweden 00 000.00 000000000 000.00
0000 000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Amsterdam, Netherlands 00 0000 00000000000 0000
To view DAMAE Medical’s complete competitors history, request access »

DAMAE Medical Patents

DAMAE Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3103894-A1 Line scanning microscopy devices and methods Pending 03-Dec-2019 0000000000
EP-3714309-B1 Dynamic focusing system for an optical device Active 12-Jan-2018 0000000000
EP-3714309-A1 Dynamic focusing system for an optical device Granted 12-Jan-2018 0000000000
US-20200341257-A1 Dynamic focusing system for an optical device Pending 12-Jan-2018 0000000000
AU-2019207864-A1 Dynamic focusing system for an optical device Pending 12-Jan-2018 G02B21/245
To view DAMAE Medical’s complete patent history, request access »

DAMAE Medical Executive Team (3)

Name Title Board Seat Contact Info
Anaïs Barut Co-Founder, Chief Executive Officer & President
David Siret Co-Founder & Chief Technology Officer
Arnaud Dubois Co-Founder & Chief Scientific Officer
To view DAMAE Medical’s complete executive team members history, request access »

DAMAE Medical Board Members (1)

Name Representing Role Since
Philippe Peltier Kurma Partners Board Member 000 0000
To view DAMAE Medical’s complete board members history, request access »

DAMAE Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DAMAE Medical Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BNP Paribas Développement PE/Buyout Minority 000 0000 000000 0
Paris-Saclay Seed Fund Venture Capital Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
News Invest Corporation Minority 000 0000 000000 0
Partech Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »